SILVER SPRING, MD — When the FDA first announced its reassessment of butylated hydroxyanisole (BHA) in February, Commissioner Marty Makary noted that the agency would conduct further assessments into other similar ingredients.
That time has arrived, according to a recent press release from the government agency. The FDA announced two requests for information (RFIs) for the reassessment of butylated hydroxytoluene (BHT) and azodicarbonamide (ADA). Similar to BHA, the former is used to prevent the spoilage of fats and oils in various food products, including cookies. The latter’s applications include being used as a dough conditioner in breadmaking operations.



